Nanoplatform-Based Molecular Imaging
Regular price
€234.30
14 days return policy
Shipping & Delivery
Category=PDT
Category=PNRX
Category=TBN
eq_bestseller
eq_isMigrated=1
eq_nobargain
eq_non-fiction
eq_science
eq_tech-engineering
molecular medicine
nano/microfabrication
nanobiotechnology
nanomaterials
nanoparticle-based probes
nanoplatform-based molecular imaging
Product details
- ISBN 9780470521151
- Weight: 1746g
- Dimensions: 188 x 259mm
- Publication Date: 12 Apr 2011
- Publisher: John Wiley & Sons Inc
- Publication City/Country: US
- Product Form: Hardback
Secure
checkout
Fast Shipping
Easy returns
The cutting-edge guide on advancing the science of molecular imaging using nanoparticles
Nanoplathform-Based Molecular Imaging provides rationale for using nanoparticle-based probes for molecular imaging, then discusses general strategies for this underutilized, yet promising, technology. It addresses general strategies of particle synthesis and surface chemistry, applications in computed tomography optical imaging, magnetic resonance imaging, ultrasound, multimodality imaging, theranostics, and finally, the clinical perspectives of nanoimaging. This comprehensive volume summarizes the opinions of those in the forefront of research and describes the latest developments by emphasizing fundamentals and initiating hands-on application.
Xiaoyuan Chen received his PhD in chemistry from the University of Idaho and was an Associate Professor of Radiology in the School of Medicine at Stanford University before joining the National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH) as a senior investigator and the Laboratory of Molecular Imaging and Nanomedicine (LOMIN) as chief. He is the author of more than 200 scholarly articles and has edited one book to date. Dr. Chen's research interests include developing and validating novel molecular imaging probes (nanoparticles, antibodies, proteins, peptides, and small organic molecules) for better understanding of the biology, early diagnosis of disease, monitoring therapy response, and guiding drug discovery and development.
